NOVA EYE MEDICAL LIMITED - ASX Briefs

*Disclaimer

NOVA EYE MEDICAL LIMITED (ASX: EYE)

EYE: FDA Clears iTrack Advance for US Launch

NOVA EYE MEDICAL LIMITED

FDA clears Nova Eye Medical's iTrack™ Advance device for canal-based glaucoma surgery in the U.S.
U.S. launch planned for the ASCRS conference in San Diego on May 5-8, 2023.
iTrack™ Advance is a high precision hand-held delivery system for treating glaucoma, appealing to a larger market of surgeons.

2023-03-31 09:32:00

EYE: Nova Eye Completes Placement

NOVA EYE MEDICAL LIMITED

Nova Eye Medical Limited has raised A$8 million (before costs) from sophisticated and other professional investors through a Share Placement.
The Placement was conducted by Taylor Collison Limited, E&P Corporate Advisory Pty Ltd and MST Financial Services Pty Ltd as joint lead managers.
Proceeds from the Placement will be used principally to fund the expansion of the Company's Glaucoma Surgical Devices in the USA, Europe and China.

2023-03-02 08:59:00